title: Myeloablative BU, fludarabine, antithymocyte globulin and low-dose TBI in the treatment of juvenile myelomonocytic leukaemia with allogeneic haematopoietic cell transplantation.
authors.affiliation: University of Calgary, Section of Haematology/Oncology/Transplant, Alberta Children's Hospital, Calgary, Canada.
authors.forename: G M T
authors.initials: GM
authors.lastname: Guilcher
authors.affiliation: University of Calgary, Section of Haematology/Oncology/Transplant, Alberta Children's Hospital, Calgary, Canada.
authors.forename: R
authors.initials: R
authors.lastname: Moorjani
authors.affiliation: University of Calgary, Section of Haematology/Oncology/Transplant, Alberta Children's Hospital, Calgary, Canada.
authors.forename: T H
authors.initials: TH
authors.lastname: Truong
authors.affiliation: University of Calgary, Section of Haematology/Oncology/Transplant, Alberta Children's Hospital, Calgary, Canada.
authors.forename: V A
authors.initials: VA
authors.lastname: Lewis
mesh_terms: D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D002066:Busulfan / Q000008:administration & dosage*; D002675:Child, Preschool; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007223:Infant; D054429:Leukemia, Myelomonocytic, Juvenile / Q000188:drug therapy / Q000628:therapy*; D019653:Myeloablative Agonists / Q000008:administration & dosage*; D019172:Transplantation Conditioning / Q000379:methods*; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014916:Whole-Body Irradiation / Q000379:methods*
chemical_list: D000961:Antilymphocyte Serum; D019653:Myeloablative Agonists; D014740:Vidarabine; D002066:Busulfan; C024352:fludarabine